Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin 14 pseudogene 9" (ENSG00000250210) is annotated as a **pseudogene** related to the septin 14 gene. **Pseudogenes** are genomic segments similar to known genes but typically lack the ability to encode functional proteins due to mutations or truncations. There is no evidence that ENSG00000250210 produces a functional RNA or protein, and it is not referenced in disease databases or the literature as a functional molecular target. It is neither referred to as a therapeutic target nor implicated in cellular or disease processes. Most references in scientific databases to "SEPTIN14" refer to the protein-coding gene (SEPTIN14 or SEPT14, e.g. ENSG00000154997), *not* this pseudogene[1]. No information on aliases, functions, diseases, or drugs is reported for septin 14 pseudogene 9.
Not applicable (no known function or mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin 14 pseudogene 9.